Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Essential Thrombocythemia

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: NA
USOR Number: 18155

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

207495: A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM3)

  • Details

ClinicalTrials.gov ID: NCT04162210
Diagnosis Type: NA
USOR Number: 18229

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

  • Details

ClinicalTrials.gov ID: NCT03646123
Diagnosis Type: NA
USOR Number: 18013

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number: 18269

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Testicular Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Anal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Malignant Adenoma

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

8820 Huron St
Thornton, Colorado 80260
536.59 mi. away
P: (303) 386-7622

More Details View Practice Page

Pages